A
Andrew G. Nicholson
Researcher at National Institutes of Health
Publications - 512
Citations - 87875
Andrew G. Nicholson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lung cancer & Idiopathic pulmonary fibrosis. The author has an hindex of 113, co-authored 477 publications receiving 73860 citations. Previous affiliations of Andrew G. Nicholson include National Yang-Ming University & University College London.
Papers
More filters
Journal ArticleDOI
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
Kazuya Kondo,Paul Van Schil,Frank C. Detterbeck,Meinoshin Okumura,Kelly L. Stratton,Dorothy Giroux,Hisao Asamura,John Crowley,Conrad Falkson,Pier Luigi Filosso,Giuseppe Giaccone,James Huang,Jhingook Kim,Marco Lucchi,Mirella Marino,Edith M. Marom,Andrew G. Nicholson,Enrico Ruffini +17 more
TL;DR: This classification of T categories, combined with a classification of N and M categories, provides a basis for a robust tumor, node, metastasis classification system for the 8th edition of American Joint Committee on Cancer/Union for International Cancer Control stage classification.
Journal ArticleDOI
MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Hongtao Ye,Liping Gong,Liping Gong,Hongxiang Liu,Rifat Hamoudi,Sima Shirali,Liza Ho,Andreas Chott,Berthold Streubel,Reiner Siebert,Stefan Gesk,José I. Martín-Subero,John Radford,Sankar Banerjee,Andrew G. Nicholson,Renzo Ranaldi,Ellen D. Remstein,Zifen Gao,Jie Zheng,Peter G. Isaacson,Ahmet Dogan,Ming-Qing Du +21 more
TL;DR: MALT1 expression pattern is identical to that of BCL10 in normal lymphoid tissues but varies in MALT lymphomas, with high cytoplasmic expression of both MALT1 and BCL 10 characterizing those with t(14;18)(q32;q21); t(1;14)(p22;q32)‐positive cases displaying the highest MALT 1 and B CL10 mRNA expression respectively.
Journal ArticleDOI
TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.
Emma Z. Du,Peter Goldstraw,Joseph Zacharias,Olivier Tiffet,Paul J. Craig,Andrew G. Nicholson,Noel Weidner,Eunhee S. Yi +7 more
TL;DR: Prevalent TTF-1 positivity in TLs and peripheral carcinoids suggest that they may be histogenetically distinct from the central carcinoids, which are typically composed of TTF -1-negative, more rounded cells.
Journal ArticleDOI
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Srihari Veeraraghavan,Panagiota Latsi,AU Wells,Panagiotis Pantelidis,Andrew G. Nicholson,Thomas V. Colby,Patricia L Haslam,EA Renzoni,R M du Bois +8 more
TL;DR: It is concluded that bronchoalveolar lavage findings do not discriminate between usual interstitial pneumonia and nonspecificinterstitial pneumonia in patients presenting with clinical features of idiopathic pulmonary fibrosis, and have no prognostic value, once the distinction between the two has been made histologically.
Journal ArticleDOI
Bronchioloalveolar Carcinoma and Lung Adenocarcinoma: The Clinical Importance and Research Relevance of the 2004 World Health Organization Pathologic Criteria
William D. Travis,Kavita Garg,Wilbur A. Franklin,Ignacio I. Wistuba,Bradley S. Sabloff,Masayuki Noguchi,Ryutaro Kakinuma,Maureen F. Zakowski,Michelle S. Ginsberg,Robert F. Padera,Francine L. Jacobson,Bruce E. Johnson,Fred R. Hirsch,Elizabeth Brambilla,Douglas B. Flieder,Kim R. Geisinger,Frederik B. Thunnissen,Keith M. Kerr,David F. Yankelevitz,Teri J. Franks,Jeffrey R. Galvin,Douglas W. Henderson,Andrew G. Nicholson,Philip S. Hasleton,Victor L. Roggli,Ming-Sound Tsao,Federico Cappuzzo,Madeline Vazquez +27 more
TL;DR: The clinical concept of BAC needs to be reevaluated with careful attention to the new 2004 WHO criteria because of the major clinical implications and more work is needed to determine the most important prognostic pathologic features in lung adenocarcinoma.